Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial

Dianne Angus, Caroline Herd, Carolyn Stone, Julie C Stout, Marguerite Wieler, Ralf Reilmann, Craig W Ritchie, Earl Ray Dorsey, Karen Helles, Elise Kayson, David Oakes, Herminia Diana Rosas, Christina Vaughan, Peter K Panegyres, David J Ames, Anita Mei Yoke Goh, Pinky Agarwal, Andrew J Churchyard, Merima Murathodzic, Phyllis ChuaD Germaine, D L Lim, H Mack, Clement Loy, Jane F Griffith, Patrick Mitchell, Jody Corey-Bloom, Shea Gluhm, Jody L Goldstein, Leah Levi, Russell L Margolis, Nadine Yoritomo, Sarah Christine Janicki, Karen S Marder, Ronda Clouse, Carlos Singer, Henry P Moore, N Padron, Sandra K Kostyk, Allison Daley, Vicki Segro, Rajeev Kumar, Karen E Anderson, Carolyn M Drazinic, Bonnie Hennig, Martha Nance, Eric S Molho, Susan R Criswell, Mark S LeDoux, Shannon Guyot, Alessandro Iannaccone, B Jennings, Blair R Leavitt, Andrew S Feigin, Scott R Evans, Shirley H Wray, Cindy J Casaceli, Constance Orme, S Gao, Arthur Watts, Kalyca Baker, Izelle Labuschagne, Mays A El-Dairi, Sharon Fekrat, Steven M Hersch, Miriam Moscovitch-Lopatin, Rudolph E Tanzi, Steven David TargumShow 48 moreShow less